AR124267A1 - Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos - Google Patents
Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usosInfo
- Publication number
- AR124267A1 AR124267A1 ARP210103407A ARP210103407A AR124267A1 AR 124267 A1 AR124267 A1 AR 124267A1 AR P210103407 A ARP210103407 A AR P210103407A AR P210103407 A ARP210103407 A AR P210103407A AR 124267 A1 AR124267 A1 AR 124267A1
- Authority
- AR
- Argentina
- Prior art keywords
- lnp
- self
- mixing
- payload
- solutions
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 150000002632 lipids Chemical class 0.000 title abstract 4
- 239000002105 nanoparticle Substances 0.000 title abstract 4
- 239000000243 solution Substances 0.000 abstract 7
- 239000000203 mixture Substances 0.000 abstract 6
- 238000002347 injection Methods 0.000 abstract 4
- 239000007924 injection Substances 0.000 abstract 4
- 239000002245 particle Substances 0.000 abstract 4
- 239000012071 phase Substances 0.000 abstract 4
- 238000002360 preparation method Methods 0.000 abstract 4
- 238000001338 self-assembly Methods 0.000 abstract 3
- 238000009826 distribution Methods 0.000 abstract 2
- 238000005538 encapsulation Methods 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 238000013537 high throughput screening Methods 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 238000000746 purification Methods 0.000 abstract 2
- 238000011084 recovery Methods 0.000 abstract 2
- 239000008346 aqueous phase Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000005457 optimization Methods 0.000 abstract 1
- 239000012074 organic phase Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
En la presente se proporcionan métodos de alto rendimiento para optimizar y elaborar diversas composiciones de nanopartículas lipídicas (LNP) y sus usos. Por ejemplo, en algunas formas de realización, la presente divulgación proporciona un método de cribado de alto rendimiento para elaborar una composición de LNP que comprende obtener al menos dos soluciones que se pueden mezclar entre sí que comprenden una carga útil y una pluralidad de moléculas capaces de autoensamblarse y mezclar dichas al menos dos soluciones en un conjunto de condiciones controladas, mediante las cuales varían la secuencia de inyección, velocidad, volumen, relación de fase y duración de mezclado. En diversas formas de realización, la presente divulgación permite determinar la eficacia de encapsulación, distribución de tamaño de partícula, purificación, tasa de recuperación de partícula y estabilidad de formulación óptimas. Los métodos divulgados en la presente permiten una optimización eficaz de las condiciones de elaboración para la preparación de agentes terapéuticos a base de LNP. Reivindicación 1: Un método de cribado de alto rendimiento optimizado para elaborar una preparación de nanopartícula lipídica (LNP) que comprende: a. obtener una primera solución que comprende una fase acuosa; b. obtener una segunda solución que comprende una fase orgánica y una pluralidad de moléculas capaces de autoensamblarse, y en donde dichas primera y segunda soluciones se pueden mezclar entre sí; c. disolver al menos una molécula de carga útil en la primera o segunda solución; d. usar un manipulador de líquidos robótico para preparar y distribuir dichas fases con distintas composiciones en una pluralidad de cavidades; e. mezclar dichas primera y segunda soluciones para obtener nanopartículas lipídicas que encapsulan dicha carga útil usando dicho manipulador de líquidos robótico en condiciones adecuadas para la formación de LNP; en donde al menos una de las siguientes condiciones es distinta entre las diferentes cavidades: tipo de molécula de autoensamblaje, relación de composición de dicha molécula de autoensamblaje; relación y/o concentración de dicha molécula de autoensamblaje a dicha carga útil, la selección de fase, tipo de amortiguador y pH, la secuencia de inyección, velocidad de inyección, velocidad de mezclado, volumen, relación de fase, duración de inyección y duración de mezclado; f. medir al menos uno de los siguientes: eficacia de encapsulación, distribución de tamaño de partícula, purificación y tasa de recuperación de partícula y estabilidad de formulación de dichas LNP; g. determinar los parámetros óptimos para elaborar dicha preparación de LNP; y h. elaborar dicha preparación de LNP en función de dichos parámetros óptimos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063123343P | 2020-12-09 | 2020-12-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR124267A1 true AR124267A1 (es) | 2023-03-01 |
Family
ID=80218499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP210103407A AR124267A1 (es) | 2020-12-09 | 2021-12-07 | Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos |
Country Status (12)
Country | Link |
---|---|
US (1) | US20230330023A1 (es) |
EP (1) | EP4259104A1 (es) |
JP (1) | JP2023552815A (es) |
KR (1) | KR20230118129A (es) |
CN (1) | CN116669711A (es) |
AR (1) | AR124267A1 (es) |
AU (1) | AU2021396518A1 (es) |
CA (1) | CA3203463A1 (es) |
IL (1) | IL303456A (es) |
MX (1) | MX2023006792A (es) |
TW (1) | TW202237068A (es) |
WO (1) | WO2022125622A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202333653A (zh) * | 2021-10-26 | 2023-09-01 | 美商建南德克公司 | 製備脂質奈米顆粒的高通量方法及其用途 |
WO2024013149A1 (en) * | 2022-07-12 | 2024-01-18 | Sartorius Stedim Biotech Gmbh | Lipid nanoparticle production system and method of monitoring and controlling the same |
WO2024028492A1 (en) * | 2022-08-04 | 2024-02-08 | Sanofi | Quantitative assessment of rna encapsulation |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4270537A (en) | 1979-11-19 | 1981-06-02 | Romaine Richard A | Automatic hypodermic syringe |
US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
CA1283827C (en) | 1986-12-18 | 1991-05-07 | Giorgio Cirelli | Appliance for injection of liquid formulations |
GB8704027D0 (en) | 1987-02-20 | 1987-03-25 | Owen Mumford Ltd | Syringe needle combination |
US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
US4940460A (en) | 1987-06-19 | 1990-07-10 | Bioject, Inc. | Patient-fillable and non-invasive hypodermic injection device assembly |
US5339163A (en) | 1988-03-16 | 1994-08-16 | Canon Kabushiki Kaisha | Automatic exposure control device using plural image plane detection areas |
FR2638359A1 (fr) | 1988-11-03 | 1990-05-04 | Tino Dalto | Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau |
US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
US5190521A (en) | 1990-08-22 | 1993-03-02 | Tecnol Medical Products, Inc. | Apparatus and method for raising a skin wheal and anesthetizing skin |
US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
SE9102652D0 (sv) | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | Injection needle arrangement |
US5328483A (en) | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
US5334144A (en) | 1992-10-30 | 1994-08-02 | Becton, Dickinson And Company | Single use disposable needleless injector |
WO1995024176A1 (en) | 1994-03-07 | 1995-09-14 | Bioject, Inc. | Ampule filling device |
US5466220A (en) | 1994-03-08 | 1995-11-14 | Bioject, Inc. | Drug vial mixing and transfer device |
US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
US5730723A (en) | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
US5893397A (en) | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
IT1298087B1 (it) | 1998-01-08 | 1999-12-20 | Fiderm S R L | Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni |
US20050222064A1 (en) | 2002-02-20 | 2005-10-06 | Sirna Therapeutics, Inc. | Polycationic compositions for cellular delivery of polynucleotides |
US9592198B2 (en) * | 2013-10-28 | 2017-03-14 | University Of Maryland, College Park | Microfluidic liposome synthesis, purification and active drug loading |
EP3247363A4 (en) | 2015-01-21 | 2018-10-03 | Moderna Therapeutics, Inc. | Lipid nanoparticle compositions |
US20180085474A1 (en) | 2015-01-23 | 2018-03-29 | Moderna Therapeutics, Inc. | Lipid nanoparticle compositions |
DK3394030T3 (da) | 2015-12-22 | 2022-03-28 | Modernatx Inc | Forbindelser og sammensætninger til intracellulær afgivelse af midler |
WO2017147215A1 (en) * | 2016-02-22 | 2017-08-31 | The Methodist Hospital | Biomimetic proteolipid vesicle compositions and uses thereof |
US20190167811A1 (en) | 2016-04-13 | 2019-06-06 | Modernatx, Inc. | Lipid compositions and their uses for intratumoral polynucleotide delivery |
WO2017223135A1 (en) * | 2016-06-24 | 2017-12-28 | Modernatx, Inc. | Lipid nanoparticles |
-
2021
- 2021-12-07 AR ARP210103407A patent/AR124267A1/es unknown
- 2021-12-07 TW TW110145739A patent/TW202237068A/zh unknown
- 2021-12-08 EP EP21854765.1A patent/EP4259104A1/en active Pending
- 2021-12-08 KR KR1020237022439A patent/KR20230118129A/ko unknown
- 2021-12-08 AU AU2021396518A patent/AU2021396518A1/en active Pending
- 2021-12-08 CN CN202180083381.2A patent/CN116669711A/zh active Pending
- 2021-12-08 CA CA3203463A patent/CA3203463A1/en active Pending
- 2021-12-08 MX MX2023006792A patent/MX2023006792A/es unknown
- 2021-12-08 WO PCT/US2021/062344 patent/WO2022125622A1/en active Application Filing
- 2021-12-08 IL IL303456A patent/IL303456A/en unknown
- 2021-12-08 JP JP2023534898A patent/JP2023552815A/ja active Pending
-
2023
- 2023-06-09 US US18/332,324 patent/US20230330023A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2023006792A (es) | 2023-06-20 |
KR20230118129A (ko) | 2023-08-10 |
JP2023552815A (ja) | 2023-12-19 |
CA3203463A1 (en) | 2022-06-16 |
AU2021396518A1 (en) | 2023-07-06 |
TW202237068A (zh) | 2022-10-01 |
WO2022125622A1 (en) | 2022-06-16 |
US20230330023A1 (en) | 2023-10-19 |
EP4259104A1 (en) | 2023-10-18 |
IL303456A (en) | 2023-08-01 |
CN116669711A (zh) | 2023-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR124267A1 (es) | Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos | |
Huang et al. | Engineered PES/SPES nanochannel membrane for salinity gradient power generation | |
Wang et al. | What molecular assembly can learn from catalytic chemistry | |
Blosser et al. | cDICE method produces giant lipid vesicles under physiological conditions of charged lipids and ionic solutions | |
Ivankin et al. | Cholesterol mediates membrane curvature during fusion events | |
CN103196733B (zh) | 一种显示镍基高温合金的金相组织所用的侵蚀剂及方法 | |
RU2012122776A (ru) | Содержащие нуклеиновые кислоты липидные частицы и относящиеся к ним способы | |
CN108031549B (zh) | 一种用于多种粒子连续分离的磁分离装置及方法 | |
Kirchner et al. | Membrane composition of jetted lipid vesicles: a Raman spectroscopy study | |
Xu et al. | A simple and visual approach for enantioselective recognition through supramolecular gels with specific selectivity | |
CN105996038A (zh) | 一种高稳定型可控营养物释放纳米乳液的制备方法 | |
JP7233632B2 (ja) | 磁気相互作用を用いたキラル化合物の分離システムおよび方法 | |
CN107519814A (zh) | 阴/阳离子表面活性剂构筑的ph调控型粘弹溶液及应用 | |
Lim et al. | The more exotic shapes of semiconductor nanocrystals: emerging applications in bioimaging | |
Wang et al. | Jet flow directed supramolecular self-assembly at aqueous liquid–liquid interface | |
Chen et al. | Supramolecular Copolymers Under Kinetic, Thermodynamic, or Pathway‐Switching Control | |
Napiwocki et al. | Aligned human cardiac syncytium for in vitro analysis of electrical, structural, and mechanical readouts | |
JP2022505763A (ja) | イリノテカンリポソーム製剤とその製造及び応用 | |
CN102675412B (zh) | 一种制备蛋白质晶体的方法 | |
CN103128309B (zh) | 水溶性生物相容性单分散球形金纳米晶体的合成方法 | |
AR127469A1 (es) | Métodos de alto rendimiento para preparar nanopartículas lipídicas y sus usos | |
CN103360459B (zh) | 恒流扩散的蛋白质结晶方法和开放式恒流扩散蛋白质结晶阵列芯片及其制作方法和应用 | |
Bhosale et al. | Recent developments in utilising yoctowells for investigations in nanospace | |
Wang et al. | DNA nanochannels | |
Lin et al. | Controllable 1D, 2D and 3D supramolecular assemblies of Ir (iii) complexes |